Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage

Stroke

Volumn 31, Issue 4, 2000, Pages 901-906

  Naredi, Silvana ^b   Lambert, G ^a   Eden E ^c   Zall S ^c   Runnerstam, M ^c   Rydenhag, B ^c   Friberg, P ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c NONE

Author keywords

Norepinephrine; Subarachnoid hemorrhage; Sympathetic nervous system

Indexed keywords

CATECHOLAMINE; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN VASOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; SYMPATHETIC REFLEX; SYMPATHETIC TONE;

EID: 0034086307     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.4.901     Document Type: Article

References (46)

1. Cruickschank JM, Neil-Dwyer G, Stott AW. Possible role of catecholamines, corticosteroids, and potassium in production of electrocardiographic abnormalities associated with subarachnoid hemorrhage. Br Heart J. 1974;36:697-706.
2. Grad A, Kiauta T, Osredkar J. Effect of elevated plasma norepinephrine on electrocardiographic changes in subarachnoid hemorrhage. Stroke. 1991;22:746-749.
3. Dilraj A, Botha JH, Rambiritch V, Miller R, van Dellen JR. Levels of catecholamine in plasma and cerebrospinal fluid in aneurysmal subarachnoid hemorrhage. Neurosurgery. 1992;31:42-51.
4. Goldstein DS. Stress, Catecholamines and Cardiovascular Disease. New York, NY: Oxford University Press; 1995;60-258.
5. Marion DW, Segal R, Thompson ME. Subarachnoid hemorrhage and the heart. Neurosurgery. 1986;18:101-106.
6. Mayer SA, Swarup R, Neurogenic cardiac injury after subarachnoid hemorrhage. Curr Opin Anaesthesiol. 1996;5:356-361.
7. Lanzino G, Kongable GL, Kassel NF. Electrocardiographic abnormalities after nontraumatic subarachnoid hemorrhage. J Neurosurg Anesthesiol. 1994;6:156-162.
8. Rudehill A, Gordon E, Sundquist K, Sylvén C, Wahlgren NG. A study of ECG abnormalities and myocardial specific enzymes in patients with subarachnoid hemorrhage. Acta Anaesth Scand. 1982;26:344-350.
9. Kono T, Monta H, Kurioiwa T, Onaka H, Takatsuka H, Fujiwara A. Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage, neurogenic stunned myocardium. J Am Coll Cardiol. 1994;24: 636-640.
10. Brouwers PJAM, Westenberg HGM, Van Gijn J. Norepinephrine concentrations and electrocardiographic abnormalities after aneurysmal subarachnoid hemorrhage. J Neurol Neurosurg Psych. 1995;58:614-617.
11. Svigelj V, Grad A, Kiauta T. Heart rate variability, norepinephrine and ECG changes in subarachnoid hemorrhage patients. Acta Neurol Scand. 1996;94:120-126.
12. Lambert GW, Kaye DM, Lefkovits J, Jennings GL, Turner AG, Cox HS, Esler MD. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. Circulation. 1995;92:1813-1818.
13. Kaye DM, Lambert GW, Lefkovits J, Morris M, Jennings G, Esler MD. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol. 1994;23:570-578.
14. Esler M, Jennings G, Lambert G, Meredith I, Home M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate and functions. Physiol Rev. 1990;70:963-985.
15. Eisenhofer G, Rundquist B, Aneman A, Friberg P, Dakak N, Kopin IJ, Jacobs MC, Lenders JW. Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. J Clin Endocrinol Metab. 1995;80:3009-3017.
16. Esler M, Jackmann G, Bobik A, Kelleher D, Jennings G, Leonard P, Skews H, Korner P. Determination of norepinephrine apparent release rate and clearance in humans. Life Sci. 1979;25:1461-1470.
17. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14-20.
18. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6:1-9.
19. Robinson MJ, Teasdale GM. Calcium antagonists in the management of subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev. 1990;2: 205-226.
20. Eisenhofer G, Esler MD, Goldstein DS, Kopin IJ. Neuronal uptake, metabolism, and release of tritium-labeled norepinephrine during assessment of its plasma kinetics. Am J Physiol. 1991;261:E505-E515.
21. Medvedev OS, Esler MD, Angus JA, Cox HS, Eisenhofer G. Simultaneous determination of plasma norepinephrine and epinephrine kinetics. Responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit. Naunyn Schmiedebergs Arch Pharmacol. 1990;341:192-199.
22. Cushing HS. Some experimental and clinical observations concerning states of increased intracranial tension. Am J Med Sci. 1902;124: 375-400.
23. Van der Zee H, Neuman PH, Minnear FL, Malik AB. Effects of transient intracranial hypertension on lung fluid and protein exchange. J Appl Physiol. 1983;54:174-184.
24. Delgado TL, Brismar J, Svendgaard NA. Subarachnoid hemorrhage in the rat: angiography and fluorescein microscopy of the major cerebral arteries. Stroke. 1985;16:595-602.
25. van Wylen DG, D'Alecy LG. Regional blood flow distribution during the Cushing response: alterations with adrenergic blockade. Am J Physiol. 1985;248:H98-H108.
26. Dampney RA, Moon EA. Role of ventrolateral medulla in vasomotor response to cerebral ischemia. Am J Physiol. 1980;239:H349-H358.
27. Gebber GL, Barman SM. Lateral tegmental field neurons of cat medulla: a potential source of basal sympathetic nerve discharge. J Neurophysiol. 1985;54:1498-1512.
28. Reis DJ, Morrison S, Ruggiero DA. The C1 area of the brainstem in tonic and reflex control of blood pressure. Hypertension. 1988;11:18-13.
29. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia -the ischemic penumbra. Stroke. 1981;12:723-725.
30. Sun MK, Reis DJ. Hypoxia selectively excites vasomotor neurons of rosirai ventrolateral medulla in rats. Am J Physiol. 1994;266: R245-R256.
31. Athmanundh D, Botha JB, Rambiritch V, Miller R, van Dellen JR. Levels of catecholamines in plasma and cerebrospinal fluid in aneurysmal subarachnoid hemorrhage. Neurosurg. 1992;31:42-51.
32. Lobato RD, Marin J, Salaices M, Rivilla F, Burgos J. Cerebrovascular reactivity to noradrenaline and serotonin following experimental subarachnoid hemorrhage. J Neurosurg. 1980;53:480-485.
33. Cosentino F, Zvonimir SK, Does endothelin-1 play a role in the pathogenesis of cerebral vasospasm. Stroke. 1994;25:904-908.
34. Linnik MD, Lee TJ-F. Effects of hemoglobin on sympathetic neurovascular transmission in the porcine cerebral circulation. J Cardiovasc Pharmacol. 1993;21:615-620.
35. Levin ER. Endothelins. N Engl J Med. 1995;333:356-361.
36. Clozel M, Breu V, Burri K, Cassai JM, Fischli W, Gray GA, Hirth G, Loffler BM, Muller M, Neidhart W. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 1993;365:759-761.
37. Hirose H, Ide K, Sasaki T, Takahashi R, Kobayashi M, Ikemoto F, Vano M. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog. Eur J Pharmacol. 1995;13: 77-87.
38. Pluta RM, Oldfield EH, Boock RJ. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg. 1997;87:746-751.
39. Cruickshank JM, Neil-Dwyer G, Stott AW. Possible role of catecholamines. corticosteroids and potassium in production of electrocardiographic abnormalities associated with subarachnoid hemorrhage. Br Heart J. 1974;36:697-706.
40. Fassot C, Lambert G, Gaudet-Lambert E, Friberg P, Elghozi JL. Beneficial effect of renin-angiotensin system for maintaining blood pressure control following subarachnoid haemorrhage. Brain Res Bull. 1999;50: 127-132.
41. Lambert GW, Kaye DM, Vaz M, Cox HS, Turner AG, Jennings GL, Esler MD. Regional origins of 3-metoxy-4-hydroxyphenylglycol in plasma: effects of chronic sympathetic nervous activation and denervation and acute reflex sympathetic stimulation. J Auton Nerv Syst. 1995;55: 169-178.
42. Meredith IT, Broughton A, Jennings G, Esler MD. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med. 1991;325:618-624.
43. Cruickschank JM, Neil-Dwyer G, Hayes Y, Degaute JP, Kuurne T, Kytta J, Carruthers ME, Patel S. Stress/catecholamine-induced cardiac necrosis. Reduction by beta 1 selective blockade. Postgrad Med. 1988;29: 140-147.
44. Kolin A, Noms JW. Myocardial damage from acute cerebral lesions. Stroke. 1984;15:990-993.
45. Häggendal J, Johansson G, Jonsson L, Thoren-Tolling K. Effect of propranolol on myocardial cell necroses and blood levels of catecholamines in pigs subjected to stress. Acta Pharmacol Toxicol. 1982;50: 58-66.
46. Karlsson AK, Elam M, Lonnroth P, Sullivan L, Friberg P. Differentiated norepinephrine spillover in human skeletal muscle. Am J Physiol. 1997;273:R16-R21.